Evidence map›Paper›PMID 38980046›Full record

ArticleApplied and environmental microbiology2024

Phage display-derived alpaca nanobodies as potential therapeutics for

Wei-Chu Wang, Jungshan Chang, Chi-Hsin Lee, Yu-Wei Chiang, Sy-Jye Leu, Yan-Chiao Mao, Jen-Ron Chiang, Chun-Kai Yang, Chao-Jung Wu, Yi-Yuan Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Applied and environmental microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wei-Chu WangPh.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.ORCID 0000-0002-5452-5537
Jungshan Chang *Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Chi-Hsin Lee *Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.ORCID 0000-0002-3412-7400
Yu-Wei ChiangDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan.
Sy-Jye LeuGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Yan-Chiao MaoPh.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Jen-Ron ChiangBioproduction Plants, National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.
Chun-Kai YangInterdisciplinary Research on Ecology and Sustainability, National Dong Hwa University, Hualien, Taiwan.
Chao-Jung Wu *Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.ORCID 0000-0002-5867-9402
Yi-Yuan Yang *Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.ORCID 0000-0003-2534-8436

Funding

National Science and Technology Council (NSTC) MOST 109-2320-B-038-053National Science and Technology Council (NSTC) MOST 110-2320-B-075A-001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntiveninsCamelids, New WorldElapid VenomsSingle-Domain AntibodiesSnake BitesAnimalsCell Surface Display TechniquesMiceNaja najaPeptide LibraryAntiveninsElapid VenomsPeptide LibrarySingle-Domain AntibodiesNaja atrananobodiesphage displaysnake venom antidotesVHH

Identifiers

PMID38980046
PMCPMC11337809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.